Aethlon Medical, Inc. AEMD

Company Overview

Aethlon Medical, Inc. is a U.S.-based biotechnology and medical device company focused on developing therapeutic technologies designed to treat cancer and life-threatening infectious diseases. The company operates primarily within the biopharmaceutical, oncology, and extracorporeal blood filtration industries. Its core technology platform is the Hemopurifier®, an investigational blood filtration device intended to remove disease-promoting extracellular vesicles and certain viruses from the bloodstream. Aethlon Medical’s activities are centered on clinical-stage development, regulatory advancement, and strategic research collaborations rather than large-scale commercial product sales.

The company’s primary revenue sources historically have consisted of government contracts, research grants, collaborative agreements, and limited device-related development funding rather than recurring commercial healthcare revenue. Aethlon Medical has positioned itself within the emerging field of therapeutic apheresis and extracorporeal immunotherapy, with a strategic emphasis on oncology applications and viral pathogen removal technologies. Founded in 1984 and headquartered in San Diego, California, the company evolved from early infectious disease filtration research into a broader precision blood purification platform targeting oncology and critical care applications.